SIC
HALO icon

Samalin Investment Counsel’s Halozyme HALO Stock Holding History

Samalin Investment Counsel’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,729
Closed -$685K – 307
2025
Q1 		$685K Buy
10,729
+122
+1% +$7.09K 0.28% 107
2024
Q4 		$507K Buy
10,607
+860
+9% +$44.1K 0.22% 145
2024
Q3 		$558K Sell
9,747
-2,205
-18% -$126K 0.24% 132
2024
Q2 		$626K Sell
11,952
-540
-4% -$23.7K 0.29% 102
2024
Q1 		$508K Buy
12,492
+316
+3% +$11.8K 0.24% 134
2023
Q4 		$450K Buy
12,176
+1,419
+13% +$53.4K 0.23% 145
2023
Q3 		$411K Buy
10,757
+4,120
+62% +$169K 0.24% 129
2023
Q2 		$239K Buy
+6,637
New +$226K 0.13% 219

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Samalin Investment Counsel's HALO Position: Q2 2025 in Review

Samalin Investment Counsel sold out of Halozyme (HALO) in Q2 2025, closing a stake of 10,729 shares — an estimated $685K sold.

Samalin Investment Counsel first reported a position in HALO in Q2 2023 and held it in 8 quarters. The position peaked at $685K in Q1 2025. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

  • Samalin Investment Counsel reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
  • Samalin Investment Counsel sold 10,729 Halozyme shares in Q2 2025, an estimated $685K.
  • Samalin Investment Counsel first reported a position in Halozyme in Q2 2023 and held it in 8 quarters.
  • Samalin Investment Counsel's Halozyme position peaked at $685K in Q1 2025.
  • 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on Samalin Investment Counsel's 13F filing for Q2 2025, filed 7 Aug 2025.